# ASTEC INDUSTRIES INC (ASTE) — Financial Analysis

**Exchange:** Nasdaq  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-06-17  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/aste/thesis · /memo/aste

## Financial Snapshot

---
source: coverage-next-full
type: step_output
step: 04
ticker: ASTE
company: Astec Industries Inc
created: 2026-06-17
---

### Step 04 — Financial Quality & Adversarial Sweep
#### ASTE | Astec Industries Inc

---

#### 1. Income Statement Quality Adjustments

##### 1a. Reported vs. Adjusted Operating Income

FY2024 had substantial non-recurring / one-time charges that distort the operating earnings picture [S1]:

| Item | FY2024 ($M) | FY2023 ($M) | Notes |
|------|------------|------------|-------|
| Reported Operating Income | $23.2 | $48.6 | GAAP |
| Add: Goodwill impairment | $20.2 | $0 | Non-cash; Materials Solutions unit |
| Add: Restructuring charges | $8.4 | $13.7 | Enid operations exit, workforce reductions |
| Add: Litigation settlements | $8.4 | $7.9 | VenVer + 37 BP settlements |
| Less: Restructuring gains | $(1.1) | — | Gain on property sales |
| **Adjusted Operating Income** | **~$59.1** | **~$70.2** | Pre-impairment, pre-litigation |
| Adjusted Operating Margin | ~4.5% | ~5.2% | Still compressed vs. prior decade peak |

**Conclusion:** Even adjusting out non-recurrents, FY2024 normalized margins (~4.5%) remain well below the FY2016 peak of 7.6%. This is partly structural (ERP investment drag, elevated SG&A) and partly cyclical (Materials Solutions underperformance). [S1]

##### 1b. SG&A Inflation

SG&A has risen materially as a percentage of revenue over recent years [S1, S2]:

| FY | SG&A ($M) | % of Revenue |
|----|----------|-------------|
| 2021 | ~$221 | ~20.2% |
| 2022 | ~$255 | ~20.0% |
| 2023 | $276.4 | 20.7% |
| 2024 | $276.1 | 21.2% |

Key drivers of SG&A inflation [S1]:
- ERP transformation costs ($3.6M classified in SG&A in FY2024; multi-year)
- Personnel costs +$9.4M (SBC increase, executive transition)
- Technology and professional services +$7.7M (implementation support)
- Partially offset by: lower incentive comp (-$5.0M), reversal of litigation provision ($1.9M benefit)

**Risk:** SG&A at 21% of revenue is elevated for a capital equipment OEM. Industry peers typically run 10–15% SG&A/revenue. ASTE's elevated level reflects the ERP investment cycle and organizational build-out — management expects leverage as ERP completes (target: 2028–2029).

##### 1c. Earnings Quality Assessment

| Dimension | Rating | Notes |
|-----------|--------|-------|
| Accruals quality | Medium | Working capital swings are large (WC consumed ~$60M in FY2022) |
| Cash conversion | Poor historically | CFO/NI ratio has been erratic; FY2022 FCF was -$114.6M |
| Recurring vs. non-recurring | Concerning | 3 consecutive years of material "non-recurring" charges; 2018, 2022, 2024, 2023 all had impairments or settlements |
| Revenue recognition | Clean | ASC 606 compliant; some multi-element contracts; no channel stuffing evidence |
| Depreciation conservatism | Adequate | D&A tracking CapEx appropriately |
| Auditor change | Yellow flag | Changed from KPMG to Deloitte for FY2023 — auditor switches warrant monitoring |

---

#### 2. Balance Sheet Quality Assessment

##### 2a. Working Capital Trends

| FY | Inventory Growth | Receivables | WC vs. Sales |
|----|-----------------|-------------|--------------|
| 2021 | Rising | Rising | Stretched |
| 2022 | Very high | High | Very stretched; FCF -$115M |
| 2023 | Normalizing | Stable | Improving |
| 2024 | Normalizing | Stable | Near-normalized |

FY2022 working capital build was the largest in ASTE's history — driven by supply chain disruptions requiring higher safety stock, plus post-COVID demand surge creating large order backlog that required in-progress WIP build. The normalization since then confirms this was temporary, not structural. [S2, S4]

##### 2b. Goodwill and Intangibles

| Year | Goodwill + Intangibles ($M) | Notes |
|------|---------------------------|-------|
| 2022 | ~$165M | Pre-impairment |
| 2023 | ~$146M | Post partial impairment |
| 2024 | ~$36M | Materials Solutions fully impaired ($20.2M charge) |
| 2025 | ~$236M | Large jump — acquisition |

**FY2024 goodwill impairment: $20.2M** — the Materials Solutions reporting unit's carrying value exceeded fair value, driven by share price decline, elevated interest rates, and below-expectation segment performance. This is a legitimate concern: Materials Solutions is structurally more competitive (global players Metso, Sandvik) and margin-thin. [S1]

**FY2025 goodwill/intangibles jumped to ~$236M** (from $36M) — confirms a significant acquisition in late 2025, with acquisition premium of ~$200M+ allocated to intangibles/goodwill. [S4]

##### 2c. Debt and Leverage

| Year | LT Debt ($M) | Equity ($M) | Net Debt ($M) | Debt/EBITDA (est.) |
|------|-------------|------------|--------------|-------------------|
| 2022 | $78.3 | $626.9 | ~$12 | <1x |
| 2023 | $72.1 | $653.4 | ~$9 | <0.5x |
| 2024 | $105.0 | $637.8 | ~$14 | ~0.3x |
| 2025 | $335.8 | $681.7 | ~$264 | ~1.9x (est.) |

FY2025 leverage increase is material — net debt/EBITDA went from essentially zero to ~1.9× based on $140.7M Adj. EBITDA guidance. This is manageable but eliminates the prior balance-sheet optionality and adds interest burden (~$18–20M/year at current rates). [S2, S4, S7]

---

#### 3. Adversarial Research Sweep

**Note: This step searches for short-seller reports, negative investigations, lawsuits, regulatory actions, and accounting concerns. No earnings transcripts available; analysis based on public filings and search results.**

##### 3a. Significant Litigation (Recent)

Per FY2024 10-K [S1]:

| Case | Settlement Amount | Timing | Nature |
|------|-----------------|--------|--------|
| VenVer litigation | $8.4M paid | Q4 2024 | Contract/commercial dispute |
| 37 BP litigation | $6.3M paid ($1.9M net after contingency release) | Q3 2024 | Contract/commercial dispute |
| Brazil minority dispute | Ongoing | — | Brazilian subsidiary minority shareholder dispute (~7%) |

**VenVer and 37 BP settlements are resolved.** Total FY2024 litigation cost: ~$14.7M. No criminal, regulatory, or SEC enforcement actions identified. [S1]

##### 3b. Auditor Change (Yellow Flag)

ASTE changed auditors from **KPMG** (FY2022 and prior) to **Deloitte** (FY2023, FY2024). Auditor switches for large public companies sometimes signal disagreements over accounting treatment or audit quality concerns. However, no adverse audit opinion was issued by either firm, and the change appears to be a strategic decision rather than a dispute-driven switch. **Low-medium risk.** [S1]

##### 3c. ERP Risk

The $180–200M ERP strategic transformation is one of the largest known enterprise system projects in ASTE's history. $133M has been spent through 2024; $47–67M remaining through 2028–2029 completion. Risks:
- Cost overruns: ASTE already reduced scope (North America only vs. global originally planned) [S1]
- Manufacturing disruptions: FY2024 Q2 conversion of two plants + Corporate caused ~$22M in manufacturing inefficiency charges [S1]
- Parallel running costs: Legacy systems must run alongside SAP until each site migrates
- IT security surface: New ERP increases cyber attack surface [S1]

**This is an ongoing, multi-year execution risk — the single largest near-term operational concern.**

##### 3d. Short Seller / Negative Research

No prominent short-seller reports identified for ASTE. The stock has historically flown below the radar of activist short-sellers. No SEC enforcement actions, no restatements, no whistleblower complaints in available public records.

##### 3e. Brock Family Legacy / Governance

The Brock family (founders) retains approximately **32.67% of shares** per insider ownership disclosures. However, active management ownership (CEO, CFO, operating executives) is below 1.5% combined. Net insider sales trend in 2025–2026. The founding family's large stake could complicate strategic alternatives (e.g., acquisition premium scenarios) but is not a near-term negative catalyst. [S5]

##### 3f. Minority Interest / Brazil Dispute

ASTE holds ~93% of its Brazilian subsidiary (located in Belo Horizonte). A minority shareholder dispute is ongoing. The financial impact is expected to be small relative to total ASTE, but creates a legal overhang and complicates international expansion in Brazil. [S1]

---

#### 4. Financial Quality Score

| Dimension | Score (1–5) | Commentary |
|-----------|-------------|-----------|
| Revenue quality | 3/5 | Cyclical; lumpy equipment orders; ~25% recurring parts is a floor |
| Earnings consistency | 2/5 | Highly variable; 4 of last 8 years had material non-recurring charges |
| Cash conversion | 3/5 | FY2022 was a disaster; FY2023–2025 improving; long-term average is acceptable |
| Balance sheet | 3/5 | Clean until 2025 acquisition levered it up; now ~1.9× net debt/EBITDA |
| Accounting conservatism | 3/5 | Some concerns around non-recurring frequency; goodwill impairments are legitimate |
| Governance | 3/5 | Founder family stake creates concentration; mostly independent board is positive |
| **Overall** | **2.8/5** | **Below-average quality; cyclical industrial with execution risk overlay** |

---

#### 5. Source Index

| Ref | Source | Retrieved |
|-----|--------|----------|
| S1 | 10-K FY2024 (filed 2025-02-26) — MD&A, risk factors, litigation | 2026-06-17 |
| S2 | SEC EDGAR XBRL — Balance sheet, cash flow | 2026-06-17 |
| S4 | StockAnalysis.com | 2026-06-17 |
| S5 | proxy/governance_and_compensation.md | 2026-06-17 |
| S7 | other/consensus.md — leverage commentary | 2026-06-17 |

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/ASTE/fundamental

## Navigation

- Overview: /stocks/aste
- Financials (this page): /stocks/aste/financials
- Thesis: /stocks/aste/thesis
- Investment Memo: /memo/aste
- Coverage universe: /stocks